Medication info
Esopra Tablet 20 mg (Esomeprazole Magnesium Dihydrate)

Esopra Tablet 20 mg (Esomeprazole Magnesium Dihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›21.69mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu X 2)
Approval status
Active

MFDS item code 201508308 · Approved 2015.12.17 · Insurance code 628900520

Summary

Main use
Treatment of reflux disease and gastrointestinal disorders (ulcers, symptoms caused by anti-inflammatory analgesics, etc.), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer 20 mg of this medicine with 1 g of amoxicillin and 500 mg of clarithromycin twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning) associated with NSAID (nonselective or selective COX-2 inhibitor) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continued NSAID therapy - Treatment of gastric ulcers associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following intravenous administration to induce prevention of rebleeding due to gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. 6. Older adults No dose adjustment is necessary.
Children's dosage
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. 3. Children under 12 years of age There is no experience with administering this medicine to children under 12 years of age.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Treatment of reflux disease and gastrointestinal disorders (ulcers, symptoms caused by anti-inflammatory analgesics, etc.), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive gastroesophagitis
  • esophagitis
  • symptoms of gastroesophageal reflux disease without esophagitis
  • Helicobacter pylori positive duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • burning sensation in the upper gastrointestinal tract
  • gastric ulcers and duodenal ulcers related to non-steroidal anti-inflammatory drug administration
  • Zollinger-Ellison syndrome
  • rebleeding due to gastric ulcers and duodenal ulcers.
View approved original text

This medication is effective in treating gastroesophageal reflux disease and erosive gastroesophagitis, and is also used for long-term maintenance therapy to prevent recurrence in esophagitis patients. Additionally, it helps eliminate Helicobacter pylori in combination with antibiotics for the treatment of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. This medication is utilized in the treatment and prevention of upper gastrointestinal symptoms or gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs. It is also used for the treatment of Zollinger-Ellison syndrome and for maintenance therapy after intravenous administration to prevent rebleeding from gastric and duodenal ulcers, improving patients' symptoms. This is a medication that is effective for the treatment of various gastrointestinal diseases and related symptoms.

Dosage and Administration

Adult dosage

1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer 20 mg of this medicine with 1 g of amoxicillin and 500 mg of clarithromycin twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning) associated with NSAID (nonselective or selective COX-2 inhibitor) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continued NSAID therapy - Treatment of gastric ulcers associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following intravenous administration to induce prevention of rebleeding due to gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. 6. Older adults No dose adjustment is necessary.

Children's dosage

2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. 3. Children under 12 years of age There is no experience with administering this medicine to children under 12 years of age.

Precautions

This medication should not be administered to certain patients. For example, patients who have hypersensitivity to this medication or its ingredients, or who have previously experienced such reactions, should not take this medication. Additionally, patients allergic to amoxicillin or clarithromycin, when used in combination for the eradication of Helicobacter pylori, should not use this medication. It is also safer for women who have a history of specific heart diseases or who are nursing to avoid this medication. Various adverse reactions may occur while taking this medication. Common symptoms include headaches, abdominal pain, diarrhea, nausea, and dizziness, while serious side effects may include blood disorders, liver dysfunction, and severe skin rashes, so caution is required. In particular, if symptoms of muscle pain or weakness appear, rhabdomyolysis should be suspected, and immediate consultation with a healthcare provider is necessary. Long-term use of this medication requires regular check-ups, and if symptoms worsen or new symptoms appear, immediate consultation with a physician is necessary. This medication may reduce gastric acid, promoting bacterial growth in the stomach, which can increase the risk of infections such as diarrhea. The risk of fractures may also increase with long-term use, so caution is necessary for patients with osteoporosis. This medication has many interactions with other drugs, and dosage adjustments or caution may be required depending on the medication taken. In particular, when used in combination with antiviral drugs, anticoagulants, or anticonvulsants, it should be taken according to a doctor's instructions. The safety of this medication during pregnancy has not been fully established, so it should be used cautiously only when necessary, and nursing mothers should avoid taking it. In the case of overdose, there is no specific antidote, so appropriate treatment should be administered based on symptoms, and this medication is not removed by dialysis, so follow the healthcare provider's instructions. Finally, this medication should be kept out of the reach of children, and it is advisable not to transfer it to another container.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane adverse syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lyell syndrome, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, flushing, hypertension, tachycardia, thyroid nodule, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal developmental disorder, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorder, pharyngeal disorder, rectal disorder, gastrointestinal symptoms, increased serum gastrin, lingual disorder, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervicofacial lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, cramps, fibromyalgia syndrome, hernia, rheumatic polymyalgia, loss of appetite, apathy, increased appetite, confusion, exacerbation of depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremor, visual field defect, dysmenorrhea, menstrual disorder, vaginitis, exacerbation of asthma, cough, shortness of breath, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, pruritus ani, erythematous rash, papular rash, otitis media, dysosmia, taste loss, parageusia, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genitourinary candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric gland polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best kept at room temperature between 1 and 30 degrees Celsius. By storing it this way, the efficacy of the medication can be maintained for a long time.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu X 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.